DigestRedComo funciona
Red
/
Empresas
PB
No verificado

PBI-Gordon Companies, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaIr de comprasSalud

3 Comunicados de prensa

Ver todos los comunicados de prensa
10/09/2025
Biotecnología
Farmacéutica
Industria
Animales
Salud
Ir de compras
Medicina - Varios
PBI-Gordon Companies, Inc. Delivers Record Growth and Investment in R&D as Multi-Year Strategic Plan Is Paying Off
Fuente
PBI-Gordon Companies, Inc.
Editor
Business Wire
1.00
0
30/07/2025
Veterinaria
Higiene alimentaria
Animales
Medicina - Varios
Cardiología
Biotecnología
Salud
Ir de compras
Farmacéutica
Industria
Felycin®-CA1 (Sirolimus Delayed-Release Tablets) is the First and Only Drug FDA Approved for the Management of Ventricular Hypertrophy in Cats with Subclinical Hypertrophic Cardiomyopathy (HCM), A Condition Affecting as Many as One in Seven Cats
Fuente
PBI-Gordon Companies, Inc.
Editor
Business Wire
1.00
0
21/07/2025
Veterinaria
Salud
PBI-Gordon Companies, Inc. Calls on Petspan to Cease and Desist False and Misleading Advertisement, Promotion and Sale of Compounded Rapamycin (Sirolimus) for HCM in Cats
Fuente
PBI-Gordon Companies, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0